News Detail

London, 21 Feb 2025: An Indian pharmaceutical company is manufacturing unlicensed, highly addictive opioids and exporting them illegally to West Africa where they are driving a major public health crisis in countries including Ghana, Nigeria, and Cote......
View Details
Source : BBC World Service
Indian pharmaceutical company
highly addictive opioids
Aveo Pharmaceuticals
tapentadol
carisoprodol
Aveo logo
Related News
- DCA Telangana cracks down on overpricing and misleading drug claims (22-02-2025)
- DCA busts unlicensed manufacturing drugs unit in Sangareddy (22-02-2025)
- A committee formed in Dehradun, to address the issue of companies producing counterfeit medications (22-02-2025)
- Govt Intensifies Inspections at Pharmaceutical Facilities to Ensure Quality (22-02-2025)
- BioAsia 2025 to host Global Healthcare Leaders to drive transformative innovation (22-02-2025)
- Bihar Takes Firm Stance Against Counterfeit Medicines, Health Secretary Issues Strong Directives (22-02-2025)
- Bombay HC Quashes Income Tax Reassessment Notice Against Lupin Ltd For AY 2016-17 (22-02-2025)
- Govt extends Rajeev Singh Raghuvanshi's tenure as DCGI by one year (22-02-2025)
- CrisprBits develops PathCrisp for detection of AMR (22-02-2025)
- Medicines valued at Rs 2 lakh confiscated from Hans Foundation Chhabra office (21-02-2025)